Gerrit Dispersyn serves as Executive at RXi Pharmaceuticals Corp, where they oversee executive responsibilities. Since joining the company, Gerrit Dispersyn has executed 14 insider transactions totaling $29.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 1, 2022 involved selling 8,954 shares valued at $7.3K.
Gerrit Dispersyn currently holds 212,327 shares of RXi Pharmaceuticals Corp (RXII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gerrit Dispersyn has been a net buyer of RXII stock. They have purchased $29.5K and sold $0 worth of shares.
Gerrit Dispersyn's most recent insider trade was on Mar 1, 2022, when they sold 8,954 shares at $0.82 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 16, 2021 | PHIO | $9.8K | Purchase | 6,000 | $1.63 | Discretionary |
| Mar 4, 2021 | PHIO | $5.0K | Purchase | 1,953 | $2.56 | Discretionary |
| Mar 3, 2021 | PHIO | $7.6K | Purchase | 2,500 | $3.03 | Discretionary |
| Mar 1, 2021 | PHIO | $0 | Award | 68,450 | $N/A | Discretionary |
| Aug 19, 2020 | PHIO | $5.0K | Purchase | 2,000 | $2.50 | Discretionary |
| Mar 1, 2020 | PHIO | $2.0K | Payment | 673 | $2.93 | Discretionary |
| Nov 18, 2019 | PHIO | $35.0K | Award | 350,000 | $0.10 | Discretionary |
| Aug 1, 2019 | PHIO | $494 | Payment | 1,236 | $0.40 | Discretionary |
| Mar 1, 2019 | PHIO | $0 | Award | 407,703 | $N/A | Discretionary |
| Feb 13, 2019 | PHIO | $0 | Award | 55,000 | $N/A | Discretionary |
| Aug 1, 2018 | RXII | $0 | Award | 16,000 | $N/A | Discretionary |
| Jun 23, 2017 | RXII | $2.2K | Purchase | 3,500 | $0.62 | Discretionary |